Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E‐Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases
Pathology International · 2026
DOI: 10.1111/pin.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, 2026. Verfasst von Seiji Yamada und 15 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Innovation Center, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BRAF p.V600E‐mutant gliomas and glioneuronal tumors comprise a wide clinicopathological spectrum, yet the relationship between genomic alteration burden and histological grade remains incompletely defined. We analyzed 15 BRAF p.V600E‐mutant gliomas and glioneuronal tumors across histological grades using the PleSSision Rapid sequencing platform. Single‐nucleotide variants (SNVs) and copy‐number alterations were assessed in parallel to characterize genomic alteration profiles. Low‐grade tumors generally exhibited limited genomic alterations; however, a subset of low‐grade tumors showed increased numbers of SNVs. High‐grade tumors demonstrated more extensive genomic alterations, characterized predominantly by copy‐number gains. A trend toward increased copy‐number gains with higher WHO grade was observed. Homozygous deletion of CDKN2A was observed in pleomorphic xanthoastrocytoma, including both CNS WHO grade 2 and grade 3 tumors, and epithelioid glioblastoma. These findings indicate substantial genomic heterogeneity among BRAF p.V600E‐mutant gliomas and glioneuronal tumors. While low‐grade tumors are generally genomically quiet, a subset shows increased alterations, and high‐grade tumors tend to acquire copy‐number changes, highlighting the limitations of genomic event counts alone as a surrogate for malignant potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Innovation Center, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan.
- Department of Pathology and Cytopathology, Clinical and Educational Collaboration Unit, School of Health Sciences, Toyoake, Aichi, Japan.
- Laboratory of Genome Sequencing and Analysis, Open Facility Center, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
- Department of Neurosurgery, Shizuoka Cancer Center, Sunto, Shizuoka, Japan.
- Faculty of Health and Medical Sciences, Aichi Shukutoku University, Nagakute, Aichi, Japan.
ORCID-Profile: Seiji Yamada, Tetsuya Takimoto, Ryuta Saito
Zitieren
APA
Yamada, S., Takimoto, T., Ikeda, M., Sugihara, E., Yamaguchi, J., Deguchi, S., Aoki, K., Ohka, F., Motomura, K., Takeda, M., Ohba, S., Minamiguchi, S., Karube, K., Saito, R., Hirose, Y., & Saya, H. (2026). Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E‐Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases. Pathology International. https://doi.org/10.1111/pin.70113
Vancouver
Yamada S, Takimoto T, Ikeda M, Sugihara E, Yamaguchi J, Deguchi S, et al. Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E‐Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases. Pathology International. 2026. doi:10.1111/pin.70113
BibTeX
@article{Yamada2026,
author = {Yamada, Seiji and Takimoto, Tetsuya and Ikeda, Mina and Sugihara, Eiji and Yamaguchi, Junya and Deguchi, Shoichi and Aoki, Kosuke and Ohka, Fumiharu and Motomura, Kazuya and Takeda, Mayu and Ohba, Shigeo and Minamiguchi, Sachiko and Karube, Kennosuke and Saito, Ryuta and Hirose, Yuichi and Saya, Hideyuki},
title = {Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E‐Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases},
journal = {Pathology International},
year = {2026},
doi = {10.1111/pin.70113}
}
EUVIMED